No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:30411400-30412400 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
2 |
chr6:30411600-30412400 |
Bivalent Enhancer |
Breast Myoepithelial Primary Cells |
Breast
|
3 |
chr6:30411600-30412400 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
4 |
chr6:30411800-30412400 |
Bivalent/Poised TSS |
H1 Cell Line |
embryonic stem cell
|
5 |
chr6:30411800-30412400 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
6 |
chr6:30411800-30412400 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
7 |
chr6:30411800-30412400 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
8 |
chr6:30411800-30412400 |
Bivalent Enhancer |
Colon Smooth Muscle |
Colon
|
9 |
chr6:30411800-30412600 |
Bivalent Enhancer |
NHEK |
skin
|
10 |
chr6:30412000-30412400 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
11 |
chr6:30412000-30412400 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
12 |
chr6:30412000-30412400 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
13 |
chr6:30412000-30412400 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
14 |
chr6:30412000-30412400 |
Flanking Bivalent TSS/Enh |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
15 |
chr6:30412000-30412400 |
Flanking Active TSS |
HMEC |
breast
|
16 |
chr6:30412000-30412400 |
Flanking Bivalent TSS/Enh |
Monocytes-CD14+_RO01746 |
blood
|
17 |
chr6:30412000-30412600 |
Bivalent Enhancer |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
18 |
chr6:30412000-30412600 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
19 |
chr6:30412200-30412400 |
Flanking Bivalent TSS/Enh |
ES-WA7 Cell Line |
embryonic stem cell
|
20 |
chr6:30412200-30412400 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
21 |
chr6:30412200-30412400 |
Flanking Bivalent TSS/Enh |
HUES64 Cell Line |
embryonic stem cell
|
22 |
chr6:30412200-30412400 |
Bivalent/Poised TSS |
ES-UCSF4 Cell Line |
embryonic stem cell
|
23 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
24 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Primary neutrophils fromperipheralblood |
blood
|
25 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
26 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
27 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Muscle Satellite Cultured Cells |
--
|
28 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
29 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
30 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
31 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Placenta Amnion |
Placenta Amnion
|
32 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Sigmoid Colon |
Sigmoid Colon
|
33 |
chr6:30412200-30412400 |
Bivalent Enhancer |
NH-A |
brain
|
34 |
chr6:30412200-30412400 |
Bivalent Enhancer |
NHLF |
lung
|
35 |
chr6:30412200-30412400 |
Bivalent Enhancer |
Osteobl |
bone
|